影响HIV-HCV合并感染中丙型肝炎病毒（HCV）定量检测的分析和生物学变量。
Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.
作者信息
Cooper C L, Cooper Curtis L, MacPherson Paul, Cameron William
机构信息
University of Ottawa, Ottawa, Canada.
出版信息
Can J Gastroenterol. 2006 Jan;20(1):31-5. doi: 10.1155/2006/187241.
Abstract
The present review considers issues pertaining to the precision and variability of quantitative hepatitis C virus (HCV) measurement in general, outlines the characteristics of HCV RNA in HIV-HCV coinfection and evaluates those factors which may affect this measure. The clinical relevance of accurate HCV measurement in HIV-HCV coinfection is discussed.
摘要
本综述总体上考虑了与丙型肝炎病毒（HCV）定量检测的精密度和变异性相关的问题，概述了HIV-HCV合并感染中HCV RNA的特征，并评估了可能影响该检测的因素。文中还讨论了在HIV-HCV合并感染中准确检测HCV的临床意义。
相似文献
1
Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.
Can J Gastroenterol. 2006 Jan;20(1):31-5. doi: 10.1155/2006/187241.
2
Natural history of HIV and HCV coinfection.
J Int Assoc Physicians AIDS Care (Chic). 2003 Oct-Dec;2(4):147-51.
3
Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection.
Clin Infect Dis. 2002 Oct 1;35(7):873-9. doi: 10.1086/342388. Epub 2002 Sep 11.
4
Hepatitis C virus (HCV) and HIV coinfection.
J Int Assoc Physicians AIDS Care. 1998 Sep;4(9):58-9.
5
Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients.
HIV Med. 2014 Nov;15(10):625-30. doi: 10.1111/hiv.12166. Epub 2014 Jun 4.
6
Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes.
HIV Med. 2011 May;12(5):308-15. doi: 10.1111/j.1468-1293.2010.00886.x. Epub 2010 Oct 14.
7
Management issues in patients coinfected with hepatitis C virus and HIV.
AIDS Read. 2002 Jan;12(1):19-21, 24-6.
8
HIV and hepatitis C coinfection within the CAESAR study.
HIV Med. 2004 May;5(3):174-9. doi: 10.1111/j.1468-1293.2004.00207.x.
9
Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
J Med Virol. 2012 Mar;84(3):431-7. doi: 10.1002/jmv.23210.
10
HCV coinfection possibly promotes left ventricular dysfunction development: analysis of brain natriuretic peptide serum levels in HCV/HIV-coinfected and HIV-monoinfected patients.
Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1308-12. doi: 10.1097/MEG.0b013e32835702c6.
引用本文的文献
1
Analytical variables influencing the HCV RNA determination by TaqMan real-time PCR in routine clinical laboratory practice.
Mol Biol Rep. 2012 Jul;39(7):7421-7. doi: 10.1007/s11033-012-1574-3. Epub 2012 Feb 12.
本文引用的文献
1
Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV.
Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S105-9. doi: 10.1086/429506.
2
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
N Engl J Med. 2004 Jul 29;351(5):438-50. doi: 10.1056/NEJMoa040842.
3
Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA).
J Clin Microbiol. 2004 Feb;42(2):563-9. doi: 10.1128/JCM.42.2.563-569.2004.
4
Fluctuation of HCV viral load before seroconversion in a healthy volunteer blood donor.
Transfusion. 2003 Apr;43(4):541-4. doi: 10.1046/j.1537-2995.2003.00355.x.
5
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
N Engl J Med. 2002 Sep 26;347(13):975-82. doi: 10.1056/NEJMoa020047.
6
Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection.
Clin Infect Dis. 2002 Oct 1;35(7):873-9. doi: 10.1086/342388. Epub 2002 Sep 11.
7
Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay.
J Clin Microbiol. 2002 Mar;40(3):788-93. doi: 10.1128/JCM.40.3.788-793.2002.
8
Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum.
J Clin Microbiol. 2002 Feb;40(2):495-500. doi: 10.1128/JCM.40.2.495-500.2002.
9
Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.
J Infect Dis. 2001 Nov 1;184(9):1202-5. doi: 10.1086/323665. Epub 2001 Sep 13.
10
Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy.
J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):426-31. doi: 10.1097/00126334-200108150-00002.
Zotero 插件